GlassScriptPhysician profile
Lorena A Burillo
NPI 1548290307
$1,150.38
in general payments reported to CMS, 2019-2025
19 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $215 · 2023: $278 · 2024: $212 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.97 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $177.85 | 2021-2025 | |
| Astellas Pharma US INC | $157.30 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $106.61 | 2021-2025 | |
| Avion Pharmaceuticals | $103.88 | 2021-2023 | Balcoltra |
| Organon LLC | $86.03 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $81.73 | 2023-2025 | Slynd |
| Mayne Pharma Commercial LLC | $64.17 | 2025 | |
| Daiichi Sankyo INC. | $49.91 | 2022 | |
| Myriad Women'S Health, INC. | $40.28 | 2023 | Myrisk |
| Pfizer INC. | $40.01 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $38.44 | 2021 | |
| Shield Therapeutics INC | $35.65 | 2024-2025 | |
| Coopersurgical, INC. | $33.89 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $29.94 | 2021-2022 | |
| Sage Therapeutics, LLC | $29.79 | 2024-2025 | Zurzuvae |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $28.51 | 2022 | |
| Scynexis, INC. | $16.57 | 2022 | |
| Supernus Pharmaceuticals, INC. | $15.69 | 2025 | Qelbree |
| Mission Pharmacal Company | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorena Burillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.